Devina Mehta, MD
Dermatology in Las Vegas, NV
About Dr. Devina Mehta
Dr. Devina Mehta is a physician specializing in dermatology practicing in Las Vegas, NV, a graduate of Cincinnati College of Medicine and Surgery (2019). Treated 33 Medicare patients in 2024.
| Specialty | DermatologyOther dermatology doctors in Las Vegas |
|---|---|
| Credentials | MD |
| Education | Cincinnati College of Medicine and Surgery, 2019CMS Doctors and Clinicians |
| Gender | Female |
| NPI number | 1760042196National Provider Identifier (CMS NPPES), issued June 2019 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Where Dr. Devina Mehta practices
- Thomas Dermatology 9097 W Post Rd, Suite 100, Las Vegas, NV 89148 (702) 430-5333 · Directions · group of 37 clinicians
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Dr. Devina Mehta's specialties and state licenses
| Specialty (NPPES) | License |
|---|---|
| Dermatology Primary | NJ 25MA11884400 |
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Dr. Devina Mehta's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 23 | $99.72 |
| Biopsy of related skin growth, first growth | 14 | $97.21 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Dr. Devina Mehta's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as group. Source: CMS Care Compare, PY 2024 clinician public reporting.
Payments from drug and device companies to Dr. Devina Mehta (2025)
$2,286.21 in 90 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 88 | $2,176.57 |
| Education | 2 | $109.64 |
Paying companies: Arcutis Biotherapeutics, Inc. ($354.29), Galderma Laboratories, L.P. ($291.35), AbbVie Inc. ($273.20), Janssen Biotech, Inc. ($210.70), UCB, Inc. ($187.12), NOVARTIS PHARMACEUTICALS CORPORATION ($161.99).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Questions about Dr. Devina Mehta
What kind of clinician is Dr. Devina Mehta?
Dr. Devina Mehta is listed as a physician specializing in dermatology.
Where does Dr. Devina Mehta practice?
Thomas Dermatology at 9097 W Post Rd, Suite 100, Las Vegas, NV 89148.
What is the office phone number for Dr. Devina Mehta?
The listed office number is (702) 430-5333. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Devina Mehta?
The National Provider Identifier is 1760042196.
Does Dr. Devina Mehta accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Where did Dr. Devina Mehta go to medical school?
Cincinnati College of Medicine and Surgery, graduating in 2019.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2023-10-09 |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.